Your browser doesn't support javascript.
loading
Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study.
Kolbe, Katharina; Haffner, Ivonne; Schierle, Katrin; Maier, Dieter; Geier, Birgitta; Luber, Birgit; Bläker, Hendrik; Wittekind, Christian; Lordick, Florian.
Afiliação
  • Kolbe K; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Disease, Leipzig University Medical Center, University Cancer Center Leipzig (UCCL), Leipzig, Germany.
  • Haffner I; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Disease, Leipzig University Medical Center, University Cancer Center Leipzig (UCCL), Leipzig, Germany. ivonne.haffner@medizin.uni-leipzig.de.
  • Schierle K; Institute of Pathology, Heilbronn SLK-Kliniken GmbH, Heilbronn, Germany.
  • Maier D; Biomax Informatics AG, 82152, Planegg, Germany.
  • Geier B; Biomax Informatics AG, 82152, Planegg, Germany.
  • Luber B; Institute of Pathology, Technische Universität München, Munich, Germany.
  • Bläker H; Department of Pathology, Leipzig University Medical Center, Leipzig, Germany.
  • Wittekind C; Department of Pathology, Leipzig University Medical Center, Leipzig, Germany.
  • Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology and Infectious Disease, Leipzig University Medical Center, University Cancer Center Leipzig (UCCL), Leipzig, Germany.
J Cancer Res Clin Oncol ; 149(3): 1319-1329, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36030286

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Receptor ErbB-2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Receptor ErbB-2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article